1. Home
  2. NAMS vs CPK Comparison

NAMS vs CPK Comparison

Compare NAMS & CPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • CPK
  • Stock Information
  • Founded
  • NAMS 2019
  • CPK 1990
  • Country
  • NAMS Netherlands
  • CPK United States
  • Employees
  • NAMS N/A
  • CPK N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • CPK Oil & Gas Production
  • Sector
  • NAMS Health Care
  • CPK Utilities
  • Exchange
  • NAMS Nasdaq
  • CPK Nasdaq
  • Market Cap
  • NAMS 3.1B
  • CPK 2.9B
  • IPO Year
  • NAMS N/A
  • CPK N/A
  • Fundamental
  • Price
  • NAMS $40.29
  • CPK $138.57
  • Analyst Decision
  • NAMS Strong Buy
  • CPK Hold
  • Analyst Count
  • NAMS 10
  • CPK 2
  • Target Price
  • NAMS $44.80
  • CPK $135.00
  • AVG Volume (30 Days)
  • NAMS 1.0M
  • CPK 134.8K
  • Earning Date
  • NAMS 11-05-2025
  • CPK 11-06-2025
  • Dividend Yield
  • NAMS N/A
  • CPK 1.98%
  • EPS Growth
  • NAMS N/A
  • CPK 14.49
  • EPS
  • NAMS N/A
  • CPK 5.62
  • Revenue
  • NAMS $35,243,000.00
  • CPK $886,100,000.00
  • Revenue This Year
  • NAMS N/A
  • CPK $12.34
  • Revenue Next Year
  • NAMS N/A
  • CPK $5.79
  • P/E Ratio
  • NAMS N/A
  • CPK $24.65
  • Revenue Growth
  • NAMS 4.91
  • CPK 16.97
  • 52 Week Low
  • NAMS $14.06
  • CPK $115.12
  • 52 Week High
  • NAMS $41.47
  • CPK $140.59
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 61.84
  • CPK 63.96
  • Support Level
  • NAMS $36.59
  • CPK $134.85
  • Resistance Level
  • NAMS $40.88
  • CPK $138.62
  • Average True Range (ATR)
  • NAMS 2.59
  • CPK 3.04
  • MACD
  • NAMS -0.09
  • CPK 0.45
  • Stochastic Oscillator
  • NAMS 90.44
  • CPK 86.54

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About CPK Chesapeake Utilities Corporation

Chesapeake Utilities Corp is a diversified energy delivery company that is engaged in natural gas transmission and distribution, electricity generation and distribution, propane gas distribution, mobile compressed natural gas utility services and solutions and other businesses. The company operates in two reportable segments, Regulated Energy and Unregulated Energy. The company's natural gas and electric distribution operations in Delaware, Maryland and Florida are subject to regulation by PSC. Eastern Shore, its natural gas transmission is subject to regulation by the FERC and Peninsula Pipeline and Aspire Energy Express, its intrastate pipeline subsidiaries, are subject to regulation by the Florida PSC and Public Utilities Commission of Ohio, respectively.

Share on Social Networks: